Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism

The burden of obesity and associated cardiometabolic diseases has been considered as an important risk factor for lupus patients. Therefore, whether obesity is involved in the over-activation of autoimmune response has attracted more and more attention. Hydroxychloroquine is a synthetic antimalarial...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Pharmacol
Glavni autori: Qiao, Xin, Zhou, Zhuo-Chao, Niu, Rui, Su, Yu-Tong, Sun, Yue, Liu, Hong-Lei, Teng, Jia-Lin, Ye, Jun-Na, Shi, Hui, Yang, Cheng-De, Cheng, Xiao-Bing
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689966/
https://ncbi.nlm.nih.gov/pubmed/31427967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00855
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items